Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07323368Recruiting
Randomised, open-label trial in ischemic stroke (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Proportion of patients with a modified Rankin Scale score of 0 or 1 at 90 days. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07323368.